IVAX/NaPro
Executive Summary
Companies announce agreement giving IVAX subsidiary Baker Norton Pharmaceuticals exclusive rights to develop and market taxol supplied by Boulder, Colo.-based NaPro Biotherapeutics worldwide, with the exception of Australia, New Zealand, and parts of the Far East. Miami-based IVAX also acquires 20% of NaPro's outstanding stock through a wholly owned subsidiary.